Intas Contributes two million tablets of hydroxychloroquine for Global Trials Against COVID-19 Medical Dialogues Bureau3 April 2020 10:15 AM ISTIntas will provide up to two million tablets of hydroxychloroquine to the trial, free of charge, along with two million tablets of matched placebo.
USFDA partially lifts import ban on Ipca Labs APIs of Chloroquine Phosphate and Hydroxychloroquine Sulphate Medical Dialogues Bureau23 March 2020 1:45 PM ISTMumbai: IPCA Labs has announced that due to the shortage implications and/or medical necessity of certain drugs and finished products, the United...
